The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study
A Mekinian, MG Lazzaroni, A Kuzenko… - Autoimmunity …, 2015 - Elsevier
In European multicenter study, we aimed to describe the real-life hydroxychloroquine use in
APS patients during pregnancy and determine its benefit in refractory obstetrical APS. We …
APS patients during pregnancy and determine its benefit in refractory obstetrical APS. We …
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult …
PE Gavand, I Serio, L Arnaud… - Autoimmunity …, 2017 - Elsevier
Objectives Macrophage activation syndrome (MAS) is a life-threatening hyperinflammatory
syndrome that can occur during systemic lupus erythematosus (SLE). Data on MAS in adult …
syndrome that can occur during systemic lupus erythematosus (SLE). Data on MAS in adult …
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis …
C Comarmond, C Pagnoux, M Khellaf… - Arthritis & …, 2013 - Wiley Online Library
Objective Earlier studies of eosinophilic granulomatosis with polyangiitis (Churg‐
Strauss)(EGPA), with limited patient numbers and followup durations, demonstrated that …
Strauss)(EGPA), with limited patient numbers and followup durations, demonstrated that …
[HTML][HTML] Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
L Guillevin, C Pagnoux, A Karras… - … England Journal of …, 2014 - Mass Medical Soc
Background The combination of cyclophosphamide and glucocorticoids leads to remission
in most patients with antineutrophil cytoplasm antibody (ANCA)–associated vasculitides …
in most patients with antineutrophil cytoplasm antibody (ANCA)–associated vasculitides …
Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): report of 26 patients and review of the literature
Background Although peripheral nervous system involvement is common in eosinophilic
granulomatosis with polyangiitis (EGPA), central nervous system (CNS) manifestations are …
granulomatosis with polyangiitis (EGPA), central nervous system (CNS) manifestations are …
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised …
P Charles, B Terrier, É Perrodeau, P Cohen… - Annals of the …, 2018 - ard.bmj.com
Objective To compare individually tailored, based on trimestrial biological parameter
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of …
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of …
Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies
K Mariampillai, B Granger, D Amelin, M Guiguet… - JAMA …, 2018 - jamanetwork.com
Importance Idiopathic inflammatory myopathies are heterogeneous in their pathophysiologic
features and prognosis. The emergence of myositis-specific autoantibodies suggests that …
features and prognosis. The emergence of myositis-specific autoantibodies suggests that …
Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody–associated vasculitis: a randomized trial
P Charles, É Perrodeau, M Samson… - Annals of internal …, 2020 - acpjournals.org
Background: Biannual rituximab infusions over 18 months effectively maintain remission
after a “standard” remission induction regimen for patients with antineutrophil cytoplasmic …
after a “standard” remission induction regimen for patients with antineutrophil cytoplasmic …
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
R Seror, G Baron, E Hachulla, M Debandt… - Annals of the …, 2014 - ard.bmj.com
Objectives To evaluate the effect of adding a 10-week treatment of adalimumab to a
standardised treatment with corticosteroids on the ability to taper more rapidly corticosteroid …
standardised treatment with corticosteroids on the ability to taper more rapidly corticosteroid …
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty‐seven patients
M Jachiet, B Flageul, A Deroux… - Arthritis & …, 2015 - Wiley Online Library
Objective Hypocomplementemic urticarial vasculitis (HUV) is an uncommon vasculitis of
unknown etiology that is rarely described in the literature. We undertook this study to …
unknown etiology that is rarely described in the literature. We undertook this study to …